Related Experiment Videos

Codeine intoxication in the neonate

B Magnani1, R Evans

  • 1Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston University School of Medicine, MA 02118, USA. magnani@zeus.bwh.harvard.edu

Pediatrics
|December 10, 1999
PubMed

Insights

Routine opiate use in infants requires caution. Neonates metabolize drugs differently, leading to potential codeine intoxication, as seen in a recent case study involving cough treatment.

Area of Science:

  • Pediatric Pharmacology
  • Neonatal Toxicology
  • Clinical Case Reports

Background:

  • Opiates offer pain and cough relief but require careful administration in infants.
  • Infants, especially neonates, possess immature physiological and biochemical systems impacting drug metabolism.
  • Standard pediatric dosing does not always translate from adult dosages due to developmental differences.

Observation:

  • A case of codeine intoxication occurred in a neonate.
  • The neonate received codeine for cough suppression.
  • The prescription was issued during an emergency department visit.

Findings:

  • Neonates are uniquely susceptible to adverse drug events due to immature drug metabolism.
  • Codeine intoxication can occur in neonates even when prescribed for common symptoms like cough.
  • Physiological immaturity in neonates significantly alters drug pharmacokinetics and pharmacodynamics.

Implications:

  • Highlights the critical need for cautious opiate prescribing in the neonatal population.
  • Underscores the importance of considering unique neonatal physiology in pharmacotherapy.
  • Suggests a need for enhanced awareness and potentially revised guidelines for opiate use in neonates.

Related Concept Videos